Epididymitis following Cytoreductive Surgery with Intraperitoneal Oxaliplatin Chemotherapy: Two Case Reports
- PMID: 27293401
- PMCID: PMC4899646
- DOI: 10.1159/000443726
Epididymitis following Cytoreductive Surgery with Intraperitoneal Oxaliplatin Chemotherapy: Two Case Reports
Abstract
Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy has emerged as an aggressive treatment option with intent to either cure or extend disease-free survival of selected patients with peritoneal carcinomatosis. However, postoperative complications are common. We describe the cases of 2 men who underwent CRS with hyperthermic intraperitoneal oxaliplatin and developed scrotal pain, which was consistent with noninfectious epididymitis.
Keywords: Cytoreductive surgery; Epididymitis; Hyperthermic intraperitoneal chemotherapy; Oxaliplatin.
Figures
References
-
- Lang NP, Thompson C, Chu DZ, et al. Peritoneal carcinomatosis in nongynecologic malignancy: A prospective study of prognostic factors. Cancer. 1989;63:364–367. - PubMed
-
- Sadeghi B, Arvieux C, Glehen O, et al. Carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE-1 multicentric prospective study. Cancer. 2000;88:358–363. - PubMed
-
- Levine EA, Stewart JH, Russell GB, et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg. 2007;204:943–953. - PubMed
-
- Sugarbaker PH, Cunliffe WJ, Belliveau J, et al. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol. 1989;16(suppl 6):83–97. - PubMed
-
- Verwaal VJ, Bruin S, Boot H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15:754–763. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
